Gilead Sciences

Shareholder advocacy aimed at Gilead Sciences

2 recorded campaigns from 0 organizations.

• · 2024

  Not named on the source page. The filings were coordinated by the Interfaith Center on Corporate Responsibility. at Gilead Sciences

  Set up and report on a way of weighing what an extended patent monopoly would do to people's ability to get the medicine, before deciding whether to apply for follow-on patents.

  Source

• · 2014

  Shareholder proponent (not identified in available source) at Gilead Sciences

  Tie a portion of CEO compensation to non-financial measures based on patient access to the company's drugs.

  Source

How organizations asked shareholders to vote

Positions these organizations published themselves, each linked to where they published it. Nothing here is our view of how to vote.

What shareholders voted on

From Gilead Sciences’s own filings with the SEC. Support is the share of votes cast for and against, so abstentions and broker non-votes are not counted in it.

Proxy statements and vote results

Straight from Gilead Sciences’s own SEC filings. The proxy statement lists what shareholders were asked to vote on; the 8-K certifies how the vote went.

Do you represent Gilead Sciences? Claim this profile to respond to the campaigns listed here.

See something off? Help us make this better

← All companies